摘要
目的观察和分析晚期恶性梗阻性黄疸经皮介入治疗包括经皮经肝胆道穿刺引流术(PTCD)及经皮经肝胆道内支架置入术的近期(2周之内)并发症,探讨和总结相关并发症的处理经验。方法收集我院介入病房收治的晚期恶性梗阻性黄疸病例104例,60例接受PTCD,43例接受经皮经肝胆道内支架置入术,15例先行PTCD后择期再行内支架置入术,1例未能完成手术。观察和分析2周内并发症情况,总结相关处理措施和经验。结果28例患者发生并发症,严重并发症5例,死亡4例。除死亡病例外,所有患者经积极围手术期相关处理,病情转为平稳,介入治疗后黄疸明显减轻,2周左右胆红素指标基本恢复正常。结论经皮介入治疗方法包括PTCD及经皮经肝胆道内支架置入术是晚期恶性梗阻性黄疸姑息性减黄治疗的安全有效方法,严重并发症发生率及死亡率较低,合理的围手术期处理对降低并发症发生率及死亡率极为重要,绝大多数病人可转危为安。
purpose ：to observe and analyze the complications within 2 weeks of percutaneous intervention which include percutaneous transhepatic cholangial drainage（PTCD） and stenting for advanced malignant obstructive jaundice, and to summarize the experience of corresponding treatment. Methods Data of 104 cases with advanced malignant obstructive jaundice were collected. 60 cases got PTCD and 43 got stenting including 15cases got PTCD and stenting by two steps. One failed in the intervention. Then the complications were observed and analyzed within 2 weeks related with interventional treatment, and summarized experience. Results Complications occurred in 28 cases including 5 critical ones and 4 death. Except for the death, all cases got satisfying results and the serumal bilirubin decreased to nornal level within 2 weeks. Conclusion percutaneous intervention which includes PTCD and stenting is safe and effective as a palliative treatment for patients suffering from advanced malignant obstructive jaundice with low incidence of critical complications and low fatality, and reasonable peri-intervention treatment is very important for decreasing complications and fatality.
出处
《当代医学》
2009年第5期88-90,共3页
Contemporary Medicine
关键词
恶性梗阻性黄疸
并发症
经皮介入治疗
obstructive jaundice
complication
percutaneous intervention
